TrialThe Lancet. Respiratory medicine2021

Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial.

Tristan W Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.